Neuropace shares owned by Citadel Advisors
Historical chart of Citadel Advisors investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neuropace by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $125k | 18k | 6.97 |
2024-06-30 | $346k | 46k | 7.56 |
2024-03-31 | $273k | 21k | 13.20 |
2023-12-31 | $248k | 24k | 10.31 |
2022-06-30 | $109k | 22k | 5.01 |
2021-12-31 | $101k | 10k | 10.09 |
2021-09-30 | $411k | 26k | 15.91 |